



















1817
The Takara Group is founded
A new member of Fushimi’s sake-brewing community

1864
Begins brewing of shochu, mirin
and shirozake

1897
Registration of the Takara trademark
for mirin

1905
The establishment of Yomo GMK
1912
“Takara Shochu” goes on sale
1918
“Takara Shochu” (640 mL) becomes
the first bottled shochu to go on sale

1900
The founding of
Takara Shuzo Co., Ltd.

1926
Merged with Teikoku Shuzo KK


1933
The establishment of
Shochikubai Shuzo



1946
The establishment of the company motto,
“Three Points of Importance,
Three Points of Care”

1950
Major growth as Japan’s top shochu brand

1957
“Takara Beer” launches


1967
Withdrawal from the beer business
1970
Movie star Yujiro Ishihara appears in Sho Chiku Bai advertisements

Completion of Central Research Laboratories

1971
Alliance with Tomatin Spey
Distillery (U.K.)


1972
Import and sale of Chinese rice
liquors begins

1977
Takara Shochu “Jun”
is released
Shochu restoration is achieved


1954
Launching the biotechnology business
Japan’s first restriction enzymes are released

1983
Takara Sake USA Inc.
is established.


1984
Takara Can Chu-Hi is launched


1985
Takara Harmonist Fund, a charitable trust,
is established

1986
“Takara Barbican” is launched
Entered the non-alcoholic
beverage business


Takara acquires the assets of The Tomatin Distillery Co. Ltd
1988
PCR-method gene amplification system introduced for the first time in Japan

1992
Age International, Inc. (U.S.)
joins the Group

1993
PCR-related patent licenses joins the Group broadly and worldwide

Takara Biotechnology (Dalian) Co., Ltd.
is established
1994
Takara Can Chu-Hi “Deluxe” <Surioroshi Ringo> and <Arashibori Orange> are released

1995
Beijing Takara Foods is established (now Takara Shuzo Foods Co., Ltd.)

RetroNectin ® gene therapy research reagent is developed, Takara’s entry into the gene therapy sector

1998
Takara Hon-Mirin “Junryo” is released
2001
Zenryo Imo Shochu “Ikkomon” is released

Completion of the Sho Chiku Bai
“Shirakabegura,”
addressing sake market
polarization


1977
Company name changed to Takara Holdings Inc.
Splitting off the company’s alcohol and biotechnology businesses

2004
Takara Bio listed
on the Tokyo Stock Exchange Mothers Market

2005
Management control of
Clontech Laboratories, Inc. (U.S.)
joins the Group


2006
Takara “Shochu Highball” is launched

2007
“Gokujo Takara Shochu” is launched

1985
Entry into overseas Japanese food wholesale business
Management control of Foodex SAS (France) joins the Group

2011
Sho Chiku Bai Shirakabegura
“Mio,” a new sparkling sake,
is launched


2013
Management control of
Tazaki Foods Ltd. (U.K.)
joins the Group

2014
Center for Gene and Cell Processing is established

Management control of Cominport Distribución, S.L. (Spain) joins the Group
Management control of Cellartis AB
(Sweden; now Takara Bio Europe AB)
joins the Group

2016
Takara Bio is moved from the Tokyo Stock
Exchange Mothers Section to
the First Section
Mutual Trading Co., Inc. (U.S.) joins the Group

2017
Nippon Food Supplies Company Pty Ltd. (Australia) joins the Group
Takara Holdings History Museum opens

Takara Shuzo International Co., Ltd. is established

TaKaRa CRAFT
<Tochigi Yuzu>
is launched

2018
NY-ESO-1・siTCR gene therapy for synovial sarcoma designated as an eligible product under Japan’s SAKIGAKE Designation System

2020
Center for Gene and Cell Processing II
begins full-scale operations

Tokyo Mutual Trading Co., Ltd. joins the Group
Long-term management vision, TaKaRa Group Challenge for the 100th, is formulated

TaKaRa Five Values and Takara Group Sustainability Policy are established
Novel coronavirus PCR test kit is launched

2022
Zenryo Imo Shochu “ISAINA”
and Sho Chiku Bai “Subaru”
<Nama Chozo Shu (raw stored sake)>
are launched

Takara Holdings and Takara Bio
move to the Tokyo Stock Exchange Prime Market
following the exchange’s market reorganization
Takara “Karakuchi Zero Ball,”
a non-alcoholic chu-hi drink, is launched

2023
Ontario Spring Water Sake Company
(Canada) joins the Group
Center for Gene and Cell Processing III begins construction
(completion scheduled in 2027)

2024
Kagerer & Co. GmbH (Germany) joins the Group

2025
Curio Bioscience, Inc. (U.S.)
and ViSpot, Inc. join the Group